GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a prominent focus in therapeutic investigation, largely due to its notable impact on treating ailments such as second type diabetes and weight gain. Ongoing studies have revealed that beyond glucose control, GLP-1 agonists offer benefits for heart well-being and perhaps neu